SCHEMBL25818447

SCHEMBL25818447

Clc1nc(-c2cccc(-c3ccc4cccc(-c5ccc(-c6ccccc6)cc5)c4c3)c2)nc(-c2ccc3sc4ccccc4c3c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 1/20 0.38
PIM3 Q86V86 1/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
TNF P01375 1/20 0.34
LIMK1 P53667 1/20 0.33
S1PR5 Q9H228 3/20 0.33
S1PR4 O95977 2/20 0.33
ALOX5 P09917 1/20 0.33
ROCK1 Q13464 1/20 0.32
SLC9A1 P19634 1/20 0.32
CYP1A2 P05177 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818470 0.93 KDM4E (0.35) F9PIM3CA12CA1CA2
SCHEMBL25817743 0.93 F9 (0.40) F9PIM3CA12CA1CA2
SCHEMBL25818386 0.91 F9 (0.38) F9PIM3CA12CA1CA2
SCHEMBL26363520 0.91 PIM3 (0.40) PIM3LIMK1ROCK1CYP1A2KDM4E
SCHEMBL25818514 0.90 F9 (0.37) F9PIM3CA12CA1CA2
SCHEMBL22161406 0.90 HDAC8 (0.37) F9CA12CA1CA2CA9
SCHEMBL22161555 0.90 PIM3 (0.40) PIM3LIMK1ROCK1CYP1A2KDM4E
SCHEMBL25818429 0.89 ALOX5 (0.41) F9PIM3CA12CA1CA2
SCHEMBL25818459 0.89 F9 (0.36) F9CA12CA1CA2CA9
SCHEMBL25818528 0.89 PIM3 (0.38) F9PIM3LIMK1ROCK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 F9 1377/4885PIM3 3432/4885CA12 2442/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 F9 1377/4885PIM3 3432/4885CA12 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.